Explore
Validate
Learn
Western blot
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA056994 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA056994, RRID:AB_2683304
- Product name
- Anti-RRM2
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human RRM2, Gene description: ribonucleotide reductase M2, Validated applications: ICC, IHC, WB, Uniprot ID: P31350, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Membrane RRM2-positive cells represent a malignant population with cancer stem cell features in intrahepatic cholangiocarcinoma
IGF2BP3 regulates the expression of RRM2 and promotes the progression of rheumatoid arthritis via RRM2/Akt/MMP-9 pathway
Targeting of RRM2 suppresses DNA damage response and activates apoptosis in atypical teratoid rhabdoid tumor
Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma
Proteomic analysis of cell cycle progression in asynchronous cultures, including mitotic subphases, using PRIMMUS
Zhao Y, Xue S, Wei D, Zhang J, Zhang N, Mao L, Liu N, Zhao L, Yan J, Wang Y, Cai X, Zhu S, Roessler S, Ji J
Journal of Experimental & Clinical Cancer Research 2024;43(1)
Journal of Experimental & Clinical Cancer Research 2024;43(1)
IGF2BP3 regulates the expression of RRM2 and promotes the progression of rheumatoid arthritis via RRM2/Akt/MMP-9 pathway
Du Y, Ban Z, Li Z, Xing S, Ye Y
PLOS ONE 2024;19(5):e0303593
PLOS ONE 2024;19(5):e0303593
Targeting of RRM2 suppresses DNA damage response and activates apoptosis in atypical teratoid rhabdoid tumor
Giang L, Wu K, Lee W, Chu S, Do A, Changou C, Tran H, Hsieh T, Chen H, Hsieh C, Sung S, Yu A, Yen Y, Wong T, Chang C
Journal of Experimental & Clinical Cancer Research 2023;42(1)
Journal of Experimental & Clinical Cancer Research 2023;42(1)
Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma
Cheng W, Chang C, Lo C, Hsieh C, Kuo T, Tseng G, Wong S, Chiang S, Huang K, Lai L, Lu T, Chao K, Sher Y
Theranostics 2021;11(8):3661-3675
Theranostics 2021;11(8):3661-3675
Proteomic analysis of cell cycle progression in asynchronous cultures, including mitotic subphases, using PRIMMUS
Ly T, Whigham A, Clarke R, Brenes-Murillo A, Estes B, Madhessian D, Lundberg E, Wadsworth P, Lamond A
eLife 2017;6
eLife 2017;6
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Orthogonal validation
- Main image
- Experimental details
- Immunohistochemistry analysis in human lymph node and skeletal muscle tissues using HPA056994 antibody. Corresponding RRM2 RNA-seq data are presented for the same tissues.
- Sample type
- Human
- Protocol
- Protocol
